RxDoctor Payments Data

Rami Rustum, MD

Interventional Pain Medicine · Methuen, MANPI 1881694180

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,288 of the $5,830 with a category attached, or 73.5%. 30 manufacturers reported payments, led by Boston Scientific at 56.7% of the total. Reporting peaked in 2022 at $2,521 and has fallen 84.0% since, to $404 in 2025.

$5,830in general payments, 2019–2025

Across 136 payments — averaging $42.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Medtronic$444
  • Painteq LLC$271
  • Stryker$214
  • Novo Nordisk$202
  • SPR Therapeutics, Inc$182
  • plus $1K from 24 others

What the payments were for

  • Travel & lodging$1,54226%
  • Food & beverage$4,28874%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,830 in reported general payments places this provider in the 70th percentile of 22 interventional pain medicine providers in Massachusetts.

See all interventional pain medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$129,286
Medicare patients
109
Services billed
7,715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin93$2,148
Baclofen111$2,052
Oxycodone Hcl150$2,017
Fentanyl18$1,530
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen116$1,515
Morphine Sulfate ErMorphine Sulfate33$1,312
Methadone Hcl81$1,250
Pregabalin37$919
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen41$841
Hydromorphone Hcl29$330
Acetaminophen-CodeineAcetaminophen With Codeine19$237
Topiramate22$228
Tramadol Hcl35$198

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Methuen

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →